Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Harvard Bioscience announced that CEO Jim Green and CFO Jennifer Cote will present at the Jefferies Global Healthcare Conference on June 5, 2024.
The event will be held at the Marriott Marquis, New York City, from 2:00 to 2:25 PM Eastern Time.
The presentation will be webcast live via the Harvard Bioscience investor relations website, with a replay available afterwards.
Additionally, the company will host one-on-one meetings with investors during the conference.
For scheduling these meetings, investors can contact healthcareconference@jefferies.com.
Positive
- Harvard Bioscience's participation in a major healthcare conference increases visibility and investor engagement.
- The presentation will be webcast live, enhancing accessibility for a broader audience.
- One-on-one meetings with investors could foster stronger investor relations and potential investments.
Negative
- The announcement lacks detailed financial results or new business developments.
- No new clinical data or significant product announcements were made, which may not satisfy investors looking for concrete advancements.
Details
News Market Reaction – HBIO
The recorded move for HBIO in the trading session of this news was -0.63%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.
The Company’s presentation will be 2:00-2:25 PM ET on June 5th. The presentation will be webcast live and can be accessed through the investor relations section of the Harvard Bioscience website at https://investor.harvardbioscience.com. A replay will be available shortly after the presentation has concluded.
Harvard Bioscience will also host one-on-one meetings with investors in conjunction with the Conference. To schedule a one-on-one meeting, please contact healthcareconference@jefferies.com.
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at
www.harvardbioscience.com
Company Contact:
Harvard Bioscience
Jennifer Cote, Chief Financial Officer
(508) 893-3120
Investor Contacts:
Three Part Advisors
Sandy Martin / Erol Girgin / William Shelmire
HBIO@threepa.com
(214) 616-2207
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.